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Introduction
In contrast to cancer or cardiovascular disease, reproduction
is not a disease entity. Although this statement seems both ob-
vious and simplistic, the fict that reproduction refrs to a biologic
and social process as opposed to a specific pathologic entity has
profound implications for the scientist or policy maker int
in reproductive risk assessment. In addition to the familiar
methodological challenges that confront investigators of en-
vironmental influences on chronic disease, such as exposure
ascertainment and control ofconfounding variables, reproduc-
tive epidemiologists are still grappling with the most fundamen-
tal question: What constitutes reproductive risk and how do we
measure it?
Successful reproduction involves several components: the
biologic processes ofthe male and female that yield viable sperm
and a viable egg; the social and biologic interactions between the
male and the female that yield a viable conceptus; the biologic
processes within the mother and fetus that result in appropriate
growth and development ofthe fetus; and the processes that en-
sure successful parturition. Disruption of any of these com-
ponents may interfere with reproduction, but the manifestation
ofa disruption depends on the affected component and the nature
ofthe insult. Multiple effects may result from interference with
a specific biological process; conversely, each manifestation of
reproductive health has several potential etiologic pathways.
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For example, a woman whose endocrine function is distubed
may not ovulate, thus precluding pregnancy. The failure to
ovulate may be manifested as an alteration in her menstrual
cycles,-or it may not become apparent untl she tries to conceive
and fails. On the other hand, ifthe alteration in endocrine func-
tion interferes with fetal development as opposed to ovulation,
the woman will become pregnant, but the fetus may die and the
mother may miscarry, or the fetus may survive with a serious
birth defect.
Although information about environmental influences on
reproduction is quite limited, available data suggest that essen-
tially every component ofthe reproductive process is suscepti-
ble to some exogenous agent. Ovarian function is disrupted by
exposure to chemotherapeutic drugs (1), spermatogenesis is
disrupted by exposure to dibromochloropropane (2), smoking
has been associated with delayed conception (3) and low birth
weight (4), and developmental disabilities have occurred among
children exposed to methyl mercury in utero (5).
Despite this multifaceted vulnerability toenviro l insults
(6,7), researchers concerned with a potentially toxic exposure
often fail to consider multiple reproductive end points. Most
often, only one specific endpoint is studied, and medtdological
efforts focus on how to better assess that individual outcome. For
example, considerable attention is currentdy being addressed to
how best to evaluate pregnancy loss. Pregnancy loss is clearly an
important event for which etiologic actors need to be identified.
The goal ofenvironmental risk assessnent, howver, is not simp-
ly to elucidate the etiology ofa particular adverse outcome, but
to assess the overall reproductive health consequences of ex-
posure to environmental agents.
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The disease-based epidemiologic model leads to the evalua-
tion ofvarious individual endpoints, such as conception, fertility,
or child health. Reproductive risk encompasses this entire spec-
trum. Consequently, investigation of reproductive risk and the
accompanying methodological development must also address
this broader concept. In parallel with current efforts to better
evaluate specific outcomes, some thought and effort should
therefore be devoted to integation ofinformation across the spec-
trum of reproductive health.
This paper raises several methodological issues arising from
the breadth and complexity ofreproductive function. A simple,
direct question underlies the discussion: Given the exposure of
a community to a potentially toxic agent, how should we assess
the reproductive health consequences? Specifically, which
reproductive end points should we evaluate?
Selecting Reproductive End Points for
Evaluation
Unfortunately, it must be conceded at the outset that our cur-
rent level of knowledge precludes the formulation of explicit
guidelines that will ensure the right choice ofreproductive end
points. More comprehensive consideration ofthe components of
reproductive health is necessary and desirable for public health
protection, yet an exhaustive evaluation that would ensure the
absence ofany health hazard is not feasible due to practical con-
straints (time, finances, population size). Recognizing that
negative results are always subject to the challenge that the most
sensitive health measure was omitted, more complete discussion
ofthe reasoning behind the selection ofreproductive end points
would be instructive, as would post hoc examinations ofthe ac-
curacy of the assumptions which guided the initial selection. Our
limited knowledge should encourage innovation in developing
new markers ofreproductive health, such as the recently propos-
ed indicator of time to pregnancy (8), while simultaneously
evaluating traditional indicators such as fetal loss (9) and birth
weight (10).
Scientific Considerations in Selecting
Reproductive End Points
What is the Role of Clinical Severity in Selecting
Reproductive End Points?
The clinical significance ofa reproductive health event refers
to the severity ofthe outcome for the physical or mental health
ofthe mother or child. Events such as very low birth weight (<
1500 g), stillbirth, or major birth defects are considered severe
due to their life-threatening nature or need for medical interven-
tion, whereas delayed conception, subclinical miscarriage, or
minor birth anomalies are not. All other considerations being
equal, the most important outcomes to study are those with the
greatest health impact. For a variety ofreasons, however, other
considerations are often not equal.
Rarity often precludes the study ofthe most serious reproduc-
tive events (e.g., specific major birth defects), especially when
evaluating small communities. In some instances, outcomes that
are measured on a continuous scale and dichotomized for clinical
purposes may yield more information ifevaluated as continuous
measures. For example, birth weight is truncated at 2500 (low
birth weight) or 1500 (very low birth weight), and time to
pregnancy is dichotomized at 1 year to approximate the clinical
definition of infertility (1I). In both these situations, only events
in the tails ofthe distributions are analyzed as clinically signifi-
cant adverse outcomes. Shifts within the dominant part of the
distribution are ignored.
An argument can be made, however, for studying the entire
distribution of such outcomes. First, shifts in the overall distribu-
tion rather than the proportion falling into the highly deviant tail
may actually be the most useful indicator of the population's
health. The magnitude of risk from shifts within the normal
range oftime to pregnancy, for exanple, may be inconsequential
for the individual, but important on the population level.
Statistical power considerations also favor studying shifts in a
continuous measure rather than changes in the proportion ofthe
population that is substantially deviant. The underlying assump-
tion ofthis approach is that relatively modest shifts ofthe entire
distribution ofbirth weight, for example, will move some other-
wise healthy infants into the more clinically dangerous low birth
weight zone even when the population is not large enough to ex-
amine an increased risk of this more severe outcome directly.
This assumption warrants explicit evaluation.
Another argument for studying less severe outcomes is that
they often more directly reflect the biological process ofconcern.
For example, infertility is accepted as a clinically significant con-
dition that can result from a disturbance in numerous biological
mechanisms. By careful evaluation of such clinically insignifi-
cant events as a longer time to pregnancy, perturbations in the
menstrual cycle, or altered sperm motility, the biological pro-
cesses underlying infertility may be better understood and
studied with greater precision. In fact, the availability of such
subclinical windows into the underlying biological process is ar.
important consideration in reproductive epidemiology. In much
the same way that cytogenetic markers may reflect events related
to carcinogenesis (12), such indicators of reproductive function
may be markers ofmore severe pathology and potentially allow
for earlier detection of adverse effects. However, given our
limited knowledge about these functional yet clinically insignifi-
cant measures, investigators are obligated to demonstrate em-
pirical as well as theoretical links to the more severe outcomes
of ultimate public health concern.
Is There Consistency in Which Reproductive End
Points Are Vulnerable to Environmental Agents?
The most fortuitous scenario for evaluating reproductive risk
would be to have a single reproductive end point that was con-
sistently found to be most readily perurbed by environmental ex-
posures. Studies could then focus on this single end point, pro-
viding reassurance of safety if negative results were obtained,
and proceeding to ammine other end points only ifan adverse ef-
fect were found.
The varied pathways through which reproductive function can
be disturbed make such consistency unlikely. For example, the
role of dibromochloropropane in producing testicular atrophy
(13) has no utility for predicting the potential sensitivity offemale
reproductive function or fetal development to this agent.
Although that it is possible that a pattern will emerge for some
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classes ofagents (e.g., solvents), investigators currently need to
examine multiple end points.
The temporal relationship linking exposure to health outcomes
would also be expected to vary across reproductive events. As
recommended by Rothman (14), specific hypotheses should be
made regarding the duration ofexposure required for induction
ofdisease and the time after induction during which the disease
will not be apparent (latency). The traditional chronic disease
model ofmultiyear induction and latent periods is probably not
applicable to most reproductive health outcomes, so thought and
flexibility are called for in evaluating temporal relationships.
Prepregnancy exposures might be expected to affect fertility
(through various pathways in the male and female). First
trimester exposures would potentially affect fetal viability or pro-
duce birth defects. Second or third trimester exposures might af-
fect complications of pregnancy, fetal growth, or timing of
delivery. The generally brieftime periods over which exposure
can affect reproductive outcomes calls for unusual precision in
measuring the timing ofexposure but has the advantage ofallow-
ing examination of changes in health relative to changes in ex-
posure over relatively short intervals (several years).
Does an Adverse Effect on One End Point Predict
Adverse Effects on Others?
Given the need to evaluate more than one end point, an impor-
tant consideration in selection of reproductive health indices is
the potential redundancy ofinformation. Ifoutcomes are highly
correlated at the individual level, as altered menstrual patterns
and altered ovarian function are, measurement ofboth outcomes
may be unnecessary. Expenditure of resources on the more
challenging and expensive hormonal measurement ofovulation
would be unjustified ifmore readily available data on menstrual
bleeding patterns would address potential risk. Ifthe correlation
is at a community rather than individual level (e.g., ifexposure
has a similar effect on the risk of both clinically recognized
miscarriages and subclinical miscarriages), evaluation ofthe less
costly and less invasive marker is preferred.
The potential for competition among end points that occur
along a continuum must also be considered. An extremely hazar-
dous exposure that increases the frequency ofa common early
event may actually prevent a later adverse outcome (15). The
classic example is the selective loss of fetuses who would, ifthey
survived, have had congenital anomalies at birth (16). Ifan agent
effectively causes early fetal loss, the future stillbirths or birth
defect cases may, at least in theory, be prevented.
A complete understanding ofthe biological processes underly-
ing the different reproductive end points could, ideally, predict
the interrelationships among reproductive health measures and
lead to a parsimonious selection of the most convenient in-
dicators. Chromosomal damage to germ cells, for example,
could potentially result in an array ofadverse outcomes including
infertility, fetal loss, birth defects, and childhood or adult disease
(17). Stein et al. (16) have argued that.spontaneous abortions con-
stitute a preferred indicator ofgenetic damage as compared to the
study ofbirth defects because oftheir greater fiequency ofoccur-
rence. On the other hand, measurementofoutcomes with distinct
biological pathways would not yield redundant information. Ex-
posures that suppress ovulation, for example, would not
necessarily be expected to have any correlation with influences
on infant birth weight.
Our understanding of biological mechanisms is so limited,
however, that more empirical evidence regarding the interrela-
tionships among measures is needed in order to determine which
items to include in an efficient assessment battery. For example,
better data on the empirical relationships among subclinical
pregnancy loss, early and late spontaneous abortion, and
stillbirth would be very instructive regarding how much effort is
actually needed to effectively study fetal loss. Generation ofdata
that will enable development ofefficient, comprehensive assess-
ment will require simultaneous monitoring of several different
outcomes at the individual and community level. Some con-
siderations in efficiently selecting such end points are noted
below.
Does Baseline Failure Rate Predict Environ-
mental Sensitivity?
The spectrum of fallibility for reproductive events ranges from
the very rare (e.g., ectopic pregnancy, specific birth defects) to
the very common (e.g., early pregnancy loss). The most error-
prone events, those with the highest natural incidence rates,
might be the most sensitive to disturbance by environmental
agents. The rationale for this proposition is intuitive rather than
empirical. Ifthe reserve capacity for a given reproductive func-
tion is so limited that natural failure occurs with a relatively high
frequency, then each increment in stress to the system would be
expected to further increase the number of adverse outcomes.
Conversely, a process with substantial ability to withstand insult
or recover may be better able to tolerate environmental stressors
without observable effects. However, very common events such
as early fetal loss may only reflect natural fallibility and may not
be responsive to environmental influences. Empirical research
is needed to determine which of these propositions is true.
The concept ofbaseline failure rate may also be applied to sub-
populations. In principle, populations consist of immune
(disease-free regardless of exposure), doomed (diseased
regardless ofexposure), and vulnerable (susceptible to exposure-
induced disease) individuals (18). Populations with the highest
proportion ofvulnerable individuals would be expected to yield
the strongest exposure-disease associations. The baseline fre-
quency ofadverse outcomes within a population may be a marker
ofsuch vulnerability. For many adverse reproductive outcomes
such as spontaneous abortion or infertility, older women are at
higher risk. Thus, it might be expected that older women, who
naturally have a greater tendency for reproductive problems,
would be most sensitive to environmental insults.
Alternatively, it might also be argued that high-risk persons
have, by definition, other etiologic factors present that would
make the isolation of an environmental contribution more dif-
ficult. Furthermore, ifthe increment in risk from exposure is ad-
ditive, then a low baseline frequency would facilitate detection
ofan effect. Rothman and Pbole (19) have suggested that in many
circumstances, low-risk populations are most likely to manifest
detectable effects of exposure. In the few studies that have ex-
amined the effect ofexogenous agents among women with dif-
fering histories of fetal loss (20,21), the effects of exposure on
high-risk women, defined as having a history of fetal loss, were
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markedly less than the effects on women without such a history.
Further consideration ofexposure effects across the spectrum of
baseline risk is warranted.
Can Toxicological Data Indicate the Critical End
Points to Study?
Previous comments have focused on inherent characteristics
ofthe reproductive outcome as the basis for selecting end points.
Characteristics ofthe exposure should also influence this deci-
sion. Ideally, animal experiments with the environmental agents
ofinterestwold define the most relevant reproductive health end
points to evaluate after human exposure to those agents. The
complete lack oftoxicological data on most agents is the primary
limiting factor. In addition, strategies for making extrapolations
from animals to humans on a qualitative, let alone quantitative,
basis are at an early stage of development. Since each species,
including humans, seems to have unique reproductive processes,
the potential for extrapolation is uncertain (22). When direct ex-
trapolation of reproductive end points from animals to humans
is clearly not possible, available toxicological data may still of-
fer some general guidance regarding the most likely target host
(male, female, or fetus).
Is There Specificity for the Effect of an Environ-
mental Agent?
Wlth few exceptions, environmental reproductive toxins do not
seem to have unique effects. Polychlorinated biphenyls have been
linked to a pattern of discoloration at birth (23), and some
medications are associated with specific birth defects (24), but
most suggested hazards affect common reproductive outcomes
such as spontaneous abortion and low birth weight. Although
selection ofcommon outcomes improves the statistical power to
identify associations, the advantage is counterbalanced by the
difficulty of identifying etiologic associations for end points that
are adversely affected by many different agents.
Frequently, the outcome of interest is strongly predicted
by lifestyle factors (e.g., cigarette smoking, alcohol consump-
tion) or reproductive history. The distribution ofenvironmental
agents may in some cases introduce confounder-exposure
associations as well. The potential link ofhazardous exposures
in the home or workplace with lower socioeconomic status,
for example, could result in confounding by other correlates
of social class such as cigarette smoking (25,26) or inadequate
prenatal care. The challenge ofisolating effects ofenvironmen-
tal agents from lifestyle factors is commonly exacerbated by an
interest in subtle effects in the presence ofpotentially strong con-
founding. Therefore, one important direction for research is to
identify subgroups of reproductive events that are more direct-
ly and specifically affected by environmental exposures. For
example, Kline and Stein (27) divided spontaneous abortions
into those that are karyotypically normal versus those that are
karyotypically abnormal in an attempt to discover clearer
etiologic associations. Determinants of preterm delivery are
similarly worth distinguishing from determinants of small for
gestational age (4).
Practical Considerations in Selecting
Reproductive End Points
The preceding discussion addressed scientific concerns in the
selection ofend points for evaluating environmental reproduc-
tive risks. This section addresses practical considerations in
makcing such selections based on the feasibility ofmeasurement.
Which End Points Are Sufficiently Common to
Study in Small Populations?
The ability to precisely measure the frequency ofan event and
alterations in that fiequency is a function ofthe spontaneous rate
ofoccurrence ofthe event. Since exposures in the community or
workplace often occur in relatively small populations, limitations
imposed by modest study size must be recognized in the initial
selection ofend points. Obviously, more common events such as
spontaneous abortion are favored over rarer events such as
specific birth defects because small increments in risk can be
more precisely measured forcommon end points. For example,
to achieve 80% power to detect a doubling of risk in a cohort
study with equal numbers of exposed and unexposed subjects
would require approximately 125 pregnancies per group to ex-
amine fetal loss and over 700 infants per group to study all ma-
jor birth defects (aggregated) (28). Furthermore, the public
healthfinportance ofmodest increases in acommon event would
be of greater significance than a comparable increase in a rare
event.
Rarity is ofmuch less concern when an exposure has highly
specific effects. Specific birth defects constitute the most
dramatic example of such specificity, in which a few cases (or
even a single case) may identify an environmental hazard. Ac-
tually, such small clusters constitute marked multiplications in
baseline risk, or, at the extreme, an infinite multiplication ofrisk
ofan otherwise nonexistent event. The attraction of identifying
such clear cause-and-effect relationships is tempered by the
relative infrequency with which such specificity has been
demonstrated.
What Behaviors Ar Required To Be at Risk for
Specific End Points?
The ease with which an end point can be studied depends in
part on the attributes or experiences that are required to con-
tribute information about a possible hazard. For instance, evalua-
tion of fertility requires a population ofcouples who are engag-
ing in unprotected intercourse, while evaluation of birth out-
comes requires a population ofpregnant women. Operational-
ly, these required attributes are defined by the units (persons,
pregnancies, births) that appear in the denominator of rates or
proportions.
Because available study size is greatly influenced by such re-
quirements, those end points that do not require pregnancy or an
attempt to become pregnant are favored. Nearly all reproductive-
age males and females can contribute information on semen
characteristics and menstrual function, regardless of marital or
fertility status. The unit at risk for miscarriage is a pregnancy.
The requirement ofpregnancy substantially reduces the size of
the informative population. More demanding and restrictive is
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the requirement for a planned pregnancy, since only about half
ofall pregnancies are planned (29). Outcomes such as early fetal
loss, time to pregnancy, and diagnosed infertility are only detec-
table among planned pregnancies. A slightly less restricted set
of events consists of live births, the risk unit for preterm delivery
or birth defects. For studies in which outcomes are passively
monitored through medical diagnoses, an additional implicit re-
quirement defining the sample population is the seeking of
medical care (30). Estimates of available study size must
therefore focus not on the total number ofpeople in a community
but on the number of informative events.
Which End Points Can Be Monitored with
Limited Resources?
Financial constraints affect the feasibility ofconducting studies
as well as their geographic and temporal scope. The most
desirable end points, based on financial considerations, are those
that are reported in vital records. Registries can offer a unique
resource due to their comprehensiveness, accessibility on an ag-
gregate population basis, and historical availability. However,
they can only be used to monitor certain outcomes, such as
stillbirth, birth weight, gestational age, and some birth defects.
Ascertaining reproductive outcomes through medical records
is more challenging. Hospital records are useful in identifying
certain complications of pregnancy, such as pre-eclampsia and
birth defects. Records from private clinics or physicians are much
more difficult to obtain, though outcomes such as treated spon-
taneous abortions (9) and infertility (11) can be studied in this
manner.
Self-reported reproductive outcomes are typically the most
costly to identify since they require direct communication with
individuals. No alternatives exist, however, for a number of out-
comes, such as earlier spontaneous abortions and menstrual
function. Finally, studies requiring medical examination or
laboratory assays including semen analysis, hormone assays, or
monitoring of subclinical events are the most expensive to
conduct.
Can the End Point Be Accurately Reconstructed
from the Past?
Since researchers are often interested in environmental ex-
posures that occurred in the past, the amenability ofan end point
to accurate and complete historical reconstruction is often of in-
terest. As noted previously, vital and medical records are typical-
ly available historically but are restricted in scope and often in
quality (31,32). On the other hand, self-report of past events is
dependent on the subjective importance of the event to the in-
dividual. Whereas live births are well recalled, spontaneous
abortions are incompletely remembered (33). Spontaneous abor-
tions of later gestational age are more completely recalled than
those of earlier gestational age (33). For routine events such as
menstrual abnormalities or early recognized pregnancy loss,
prospective monitoring may be required (34). Subclinical events
requiring laboratory identification are also not amenable to
historical reconstruction, requiring true prospective
ascertainment.
What Will People Tolerate in Monitoring
Reproductive Health?
In addition to considerations of study size and cost, which af-
fect feasibility from the investigator's perspective, the communi-
ty's tolerance for participating in reproductive studies must also
be addressed. Reproductive behavior is a sensitive topic. This
sensitivity comes not only from the obvious sexual aspect of
these behaviors, but also from the stigma associated with
pregnancies to unmarried women and the social and moral con-
cerns regarding induced abortion. Privacy concerns often sur-
round the decision to become pregnant, especially with respect
to employment.
Another dimension of the issue of respondent tolerance is the
potential burden imposed by participation in protocols with in-
tensive collection requirements such as the prospective monitor-
ing of biological specimens for ovarian function or early
pregnancy loss. The need to design studies that monitor multi-
ple end points increases the potential for unacceptable respon-
dent burden. Protocols that include appropriate encouragement
and/or financial incentives can successfully retain participation
in such demanding ventures, but the financial and human
resources should be commensurate with the yield ofinformation.
Suggested End Points for Environmental
Reproductive Risk Assessment
In spite ofthe emphasis in this paper on articulating multiple
considerations in selecting end points, the overriding importance
ofplausible biological mechanisms should not be lost. Ifa scien-
tific basis exists for anticipating a specific consequence ofan ex-
posure, those specific end points should be the principal focus
ofany research. Logistical considerations in that selection pro-
cess are secondary to the scientific principles. Given the frequent
absence of guidance from toxicology or prior epidemiologic
studies, however, we would suggest that environmental risk
assessments include an array of relatively common, easily
measured reproductive end points. Selection of an array ofend
points is preferable to focusing on one or two arbitrarily chosen
measures, such as specific birth defects. The array should be
chosen to include diverse processes related to reproductive health
as well as different time courses ofexposure and response. Based
on these criteria, we recommend evaluation offecundability, fetal
survival, and infant health.
Fecundabilit. Important measures of reproductive function
related to conception and early pregnancy viability would include
markers of menstrual function (menstrual cycle length) as in-
dicators of female endocrine function and time to pregnancy as
a summary indicator ofthe complete array ofprocesses required
to conceive. Both are readily self-reported and do not require in-
vasive technology, although prospective data collection is
necessary for monitoring menstrual function (34). The relevant
exposure would in part be contemporaneous with the manifesta-
tion of these outcomes.
Fetal Survival. Spontaneous abortion has been proven to be
vulnerable to environmental agents. Practical considerations
favor measurement of self-reported or medically treated spon-
taneous abortions (covering the period starting about
8 - 10 weeks into pregnancy), since measurement at earlier gesta-
tional ages requires expensive and demanding procedures (9).
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Pregnancy loss is thought to result primarily from exposures dur-
ing early pregnancy, which also is the vulnerable period for birth
defects. Pregnancy loss, however, is a much more frequent
occurrence.
Infant Health. The traditional and readily ascertained
measures of infant health much as gestational age (prematurity)
and birth weight warrant consideration. These outcomes are
readily and relatively accurately ascertained from vital records,
medical records, or self-report and have been shown to respond
to a variety ofexogenous influences (4). Furthermore, the later
part of pregnancy (third trimester) is thought to be the most
critical time period for an impact of potentially hazardous
exposures.
Need for Methodological Evaluation
The current level ofknowledge, in combination with societal
demand and public health prudence, supports the conduct
of epidemiologic research to evaluate the impact of environ-
mental agents on reproductive health. Nonetheless, the
uncertainties regarding many fundamental issues underlying
selection of end points are substantial and in need of further
empirical research.
These uncertainties make further methodological evaluation
an important research priority. Some investigations are under-
taken solely for methodological evaluation, but substantive
studies assessing the relationships between exposure and
disease can and should address these issues as well. Reports
should include clear presentation ofthe rationale for the choice
of reproductive measures and the underlying assumptions
regarding such issues as the temporal relation with exposure
and expectations regarding vulnerable subpopulations. Analyses
should examine the relationship among multiple reproduc-
tive health measures to determine whether these measures
are redundant and which seem to be the most sensitive indi-
cators of reproductive risk. Environmental risk assessment
in reproductive health would be well served by ambitious
studies that creatively contend with these challenges.
The authors thank Sherry Selevan and Allen Wilcox for their helpful comments
on the manuscript.
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